Author pages are created from data sourced from our academic publisher partnerships and public sources.
Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: A multicenter study
Active ulcerative colitis (UC) is characterized by activation and infiltration of granulocytes and monocytes/macrophages into the colonic mucosa. The infiltrated leukocytes can cause mucosal damage… Expand
Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column.
The administration of steroids is not always effective for the treatment of ulcerative colitis (UC). Their long-term use often causes adverse effects which sometimes result in their stoppage and… Expand
Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease
Leukocytapheresis (LCAP), performed with a leukocyte removal filter, was administered five times, at 1-week intervals, for 5 weeks of intensive therapy and five times, at approximately 1-month… Expand
Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan.
- K. Kumagai, T. Takagi, +8 authors T. Ohnoshi
- Annals of oncology : official journal of the…
BACKGROUND Hepatitis B after the withdrawal of cytotoxic chemotherapy in hepatitis B virus (HBV) carriers is well known and may lead to fatal hepatic failure. We retrospectively analyzed the… Expand
Therapeutic leukocytapheresis for inflammatory bowel disease.
- A. Saniabadi, H. Hanai, +4 authors R. Lofberg
- Transfusion and apheresis science : official…
- 1 October 2007
The inference that granulocytes and monocytes/macrophages (GM) are part of the immunopathogenesis of inflammatory bowel disease (IBD) and hence should be targets of therapy stems from observations of… Expand
Leukocytapheresis as an Adjunct to Conventional Medication for Inflammatory Bowel Disease
- K. Sawada
- Diseases of the colon and rectum
- 1 October 2003
Inflammatory bowel disease is characterized by clinical remission and relapse caused by severe intestinal inflammation. Drug therapy for inflammatory bowel disease is associated with unpleasant side… Expand
Adacolumn for selective leukocytapheresis as a non‐pharmacological treatment for patients with disorders of the immune system: An adjunct or an alternative to drug therapy?
Inflammatory and/or autoimmune diseases like ulcerative colitis (UC) or Crohn's disease (CD) are debilitating chronic disorders that poorly respond to pharmacological interventions. Further, drug… Expand
Adsorptive granulocyte and monocyte apheresis for refractory Crohn’s disease: an open multicenter prospective study
BackgroundActive Crohn’s disease (CD) is often associated with elevated levels of platelets, granulocytes, and monocytes that are activated and resistant to apoptosis. The level of neutrophils in the… Expand
Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.
- A. Saniabadi, Tomotaka Tanaka, Toshihide Ohmori, K. Sawada, T. Yamamoto, H. Hanai
- World journal of gastroenterology
- 7 August 2014
Ulcerative colitis and Crohn's disease are the major phenotypes of the idiopathic inflammatory bowel disease (IBD), which afflicts millions of individuals throughout the world with debilitating… Expand
Granulocyte Adsorptive Apheresis for Pediatric Patients with Ulcerative Colitis
- T. Tomomasa, A. Kobayashi, +12 authors A. Morikawa
- Digestive Diseases and Sciences
- 1 April 2003
Granulocytapheresis (GCAP) has produced efficacy in adult patients with ulcerative colitis (UC) by adsorbing activated granulocytes and monocytes/macrophages. We retrospectively investigated efficacy… Expand